Delisting riskPopularity #4,483
Scienture (SCNX)
Specialty drug developer commercializing differentiated formulations for cardiovascular and CNS care.
$0.2899
vs last close+0.00 (+1.68%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 4.93% | 2.03M shares | |
|---|---|---|---|
| 16 holders · as of Jun 30, 2026 | |||
| Insiders | 16.65% | 6.84M shares | |
| 2 holders · as of Mar 12, 2026 | |||
| Other | 78.42% | 32.20M shares | |
| remainder | |||
41.06M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
16 holders · 2.03M shares · 4 new positions · 9 increased · 4 reduced · 2 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 510.4K | 1.24% | +102.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 335.0K | 0.82% | −97.2K | Aug 12, 2026 |
| Susquehanna International Group, LLP | 235.1K | 0.57% | +235.1Knew | Aug 14, 2026 |
| Vanguard Fiduciary Trust Co | 198.1K | 0.48% | 0 | Aug 13, 2026 |
| Citadel Advisors LLC | 164.9K | 0.40% | +164.9Knew | Sep 2, 2026 |
| HRT Financial LP | 132.7K | 0.32% | +132.7Knew | Aug 14, 2026 |
| XTX Topco Ltd | 104.8K | 0.26% | +57.1K | Aug 14, 2026 |
| Northern Trust Corp | 87.6K | 0.21% | +73.7K | Aug 13, 2026 |
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.